C 19 H 27 Cl 2 NO 3 PdS 3 ,triclinic, P1 (no. 2), a =9.6245(6) Å, b =10.9445(6) Å, c =12.7679(7) Å, a =101.015(1)°, b =111.510(1)°, g =93.545(1)°, V =1215.3 Å 3 , Z =2, R gt (F) =0.046, wR ref (F 2 ) =0.107, T =200 K.
Source of material
To asolution of Na 2 PdCl 4 (0.2014g,0.685 mmol) in H 2 O(20 ml) was added acridine (acr, 0.2561 g, 1.429 mmol), and the mixture wasrefluxedfor 7h.The precipitate was then separated by filtration,washedwithacetone andpentane,and driedat50°C, to give ayellowpowder(0.3369 g).Crystals suitable for X-ray diffraction analysis were obtained by slow evaporation from adimethyl sulfoxide (DMSO) solution at 90°C.
Experimental details
Hydrogen atomsw ere positioned geometrically and allowed to ride on their parent atomswith d(C-H) =0.95 Å(CH) or 0.98 Å (CH 3 )a nd U iso (H) =1 .2 U eq (C) or 1.5 U eq (C methyl [2] . Thetitle compound consists of aneutral Pd(II) complex and two DMSO solvent molecules. In the complex, the Pd(II) ion is fourcoordinated in aslightly distorted square-planar environment by one Na tom from an acridine ligand, one Sa tom of the DMSO molecule and two chloride ions. The Cl atomsare in trans conformation with respect to each other (ÐCl1-Pd1-Cl2 =176.46(6)°) and almost perpendicular to the nearly planar acridine ligand, with the bond angles ÐN1-Pd1-Cl1 =8 8.6(1)°and ÐN1-Pd1-Cl2 =89.7(1)°. In the crystal structure, the complex and the solvent molecules are linked by C-H···O andC -H···Cl hydrogen bonds with d(C···O) =3 .114 (7) 
